Baidu
map

先天性心脏病产前产后“一体化”诊疗模式中国专家共识

2022-02-10 先天性心脏病产前产后"一体化"诊疗模式专家组 中国心血管病研究

先天性心脏病(先心病)位居我国出生缺陷首位,活产儿中先心病的发病率达到1%,是婴幼儿死亡的首位原因。近年来我国先心病诊疗取得巨大进步,大部分患儿可通过择期介入或手术治疗治愈,病死率呈现持续下降。

中文标题:

先天性心脏病产前产后“一体化”诊疗模式中国专家共识

发布日期:

2022-02-10

简要介绍:

先天性心脏病(先心病)位居我国出生缺陷首位,活产儿中先心病的发病率达到1%,是婴幼儿死亡的首位原因。近年来我国先心病诊疗取得巨大进步,大部分患儿可通过择期介入或手术治疗治愈,病死率呈现持续下降。2019年,先心病介入治疗达39027例,先心病外科手术达81246例(占所有心脏大血管外科手术量的32%,居心血管外科治疗病种的首位)。但我国先心病诊疗还存在一些问题,尽管目前已发现一些先心病相关危险因素,但尚未能形成有效的一级防控措施,部分复杂重症先心病患儿往往因未能在胎儿期和出生后早期获得诊疗而夭折,因此早期诊断及治疗是目前最有效的防治策略。 

相关资料下载:
[AttachmentFileName(sort=1, fileName=先天性心脏病产前产后“一体化”诊疗模式中国专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=f3fc81c002359583, title=先天性心脏病产前产后“一体化”诊疗模式中国专家共识, enTitle=, guiderFrom=中国心血管病研究, authorId=0, author=, summary=先天性心脏病(先心病)位居我国出生缺陷首位,活产儿中先心病的发病率达到1%,是婴幼儿死亡的首位原因。近年来我国先心病诊疗取得巨大进步,大部分患儿可通过择期介入或手术治疗治愈,病死率呈现持续下降。, cover=https://img.medsci.cn/2022218/1645199738791_5579292.jpg, journalId=0, articlesId=null, associationId=2440, associationName=先天性心脏病产前产后"一体化"诊疗模式专家组, associationIntro=先天性心脏病产前产后"一体化"诊疗模式专家组, copyright=0, guiderPublishedTime=Thu Feb 10 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">先天性心脏病(先心病)位居我国出生缺陷首位</span><span style="color: #333333;">,活产儿中先心病的发病率达到1%</span><span style="color: #333333;">,是婴幼儿死亡的首位原因</span><span style="color: #333333;">。近年来我国先心病诊疗取得巨大进步,大部分患儿可通过择期介入或手术治疗治愈,病死率呈现持续下降</span><span style="color: #333333;">。2019年,先心病介入治疗达39027例,先心病外科手术达81246例(占所有心脏大血管外科手术量的32%,居心血管外科治疗病种的首位)</span><span style="color: #333333;">。但我国先心病诊疗还存在一些问题,尽管目前已发现一些先心病相关危险因素</span><span style="color: #333333;">,但尚未能形成有效的一级防控措施,部分复杂重症先心病患儿往往因未能在胎儿期和出生后早期获得诊疗而夭折,因此早期诊断及治疗是目前最有效的防治策略</span><span style="color: #333333;">。&nbsp;</span></p>, tagList=[TagDto(tagId=1808, tagName=先天性心脏病), TagDto(tagId=8291, tagName=结构性心脏病)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4383, appHits=92, showAppHits=0, pcHits=683, showPcHits=4290, likes=0, shares=11, comments=5, approvalStatus=1, publishedTime=Sat Feb 19 15:53:00 CST 2022, publishedTimeString=2022-02-10, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=FUNNYMAN, createdTime=Fri Feb 18 23:58:57 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 08:37:51 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=先天性心脏病产前产后“一体化”诊疗模式中国专家共识.pdf)])
先天性心脏病产前产后“一体化”诊疗模式中国专家共识.pdf
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2168711, encodeId=e9d32168e116d, content=感谢分享,帮助很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db6484545, createdName=ms7000002115301694, createdTime=Wed Nov 15 20:17:49 CST 2023, time=2023-11-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1213798, encodeId=f2981213e98d3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Apr 24 00:23:54 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196273, encodeId=8a4e11962e3a7, content=指南帮助很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc746428983, createdName=ms7000001680568286, createdTime=Wed Feb 23 00:00:52 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195582, encodeId=219811955828b, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61165649860, createdName=ms5000000713403107, createdTime=Mon Feb 21 09:39:41 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195277, encodeId=44f911952e7df, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220217/d818c32cf88a45fdb82be59f79b9d4da/7adadfa34e5c4875b55cc0bba0389514.jpg, createdBy=0dd26497895, createdName=U波低钾, createdTime=Sun Feb 20 09:11:03 CST 2022, time=2022-02-20, status=1, ipAttribution=)]
    2023-11-15 ms7000002115301694 来自广东省

    感谢分享,帮助很大

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2168711, encodeId=e9d32168e116d, content=感谢分享,帮助很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db6484545, createdName=ms7000002115301694, createdTime=Wed Nov 15 20:17:49 CST 2023, time=2023-11-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1213798, encodeId=f2981213e98d3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Apr 24 00:23:54 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196273, encodeId=8a4e11962e3a7, content=指南帮助很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc746428983, createdName=ms7000001680568286, createdTime=Wed Feb 23 00:00:52 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195582, encodeId=219811955828b, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61165649860, createdName=ms5000000713403107, createdTime=Mon Feb 21 09:39:41 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195277, encodeId=44f911952e7df, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220217/d818c32cf88a45fdb82be59f79b9d4da/7adadfa34e5c4875b55cc0bba0389514.jpg, createdBy=0dd26497895, createdName=U波低钾, createdTime=Sun Feb 20 09:11:03 CST 2022, time=2022-02-20, status=1, ipAttribution=)]
    2022-04-24 120c570cm03暂无昵称

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2168711, encodeId=e9d32168e116d, content=感谢分享,帮助很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db6484545, createdName=ms7000002115301694, createdTime=Wed Nov 15 20:17:49 CST 2023, time=2023-11-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1213798, encodeId=f2981213e98d3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Apr 24 00:23:54 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196273, encodeId=8a4e11962e3a7, content=指南帮助很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc746428983, createdName=ms7000001680568286, createdTime=Wed Feb 23 00:00:52 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195582, encodeId=219811955828b, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61165649860, createdName=ms5000000713403107, createdTime=Mon Feb 21 09:39:41 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195277, encodeId=44f911952e7df, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220217/d818c32cf88a45fdb82be59f79b9d4da/7adadfa34e5c4875b55cc0bba0389514.jpg, createdBy=0dd26497895, createdName=U波低钾, createdTime=Sun Feb 20 09:11:03 CST 2022, time=2022-02-20, status=1, ipAttribution=)]
    2022-02-23 ms7000001680568286

    指南帮助很大

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2168711, encodeId=e9d32168e116d, content=感谢分享,帮助很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db6484545, createdName=ms7000002115301694, createdTime=Wed Nov 15 20:17:49 CST 2023, time=2023-11-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1213798, encodeId=f2981213e98d3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Apr 24 00:23:54 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196273, encodeId=8a4e11962e3a7, content=指南帮助很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc746428983, createdName=ms7000001680568286, createdTime=Wed Feb 23 00:00:52 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195582, encodeId=219811955828b, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61165649860, createdName=ms5000000713403107, createdTime=Mon Feb 21 09:39:41 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195277, encodeId=44f911952e7df, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220217/d818c32cf88a45fdb82be59f79b9d4da/7adadfa34e5c4875b55cc0bba0389514.jpg, createdBy=0dd26497895, createdName=U波低钾, createdTime=Sun Feb 20 09:11:03 CST 2022, time=2022-02-20, status=1, ipAttribution=)]
    2022-02-21 ms5000000713403107

    谢谢

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2168711, encodeId=e9d32168e116d, content=感谢分享,帮助很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db6484545, createdName=ms7000002115301694, createdTime=Wed Nov 15 20:17:49 CST 2023, time=2023-11-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1213798, encodeId=f2981213e98d3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Apr 24 00:23:54 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1196273, encodeId=8a4e11962e3a7, content=指南帮助很大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc746428983, createdName=ms7000001680568286, createdTime=Wed Feb 23 00:00:52 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195582, encodeId=219811955828b, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61165649860, createdName=ms5000000713403107, createdTime=Mon Feb 21 09:39:41 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195277, encodeId=44f911952e7df, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220217/d818c32cf88a45fdb82be59f79b9d4da/7adadfa34e5c4875b55cc0bba0389514.jpg, createdBy=0dd26497895, createdName=U波低钾, createdTime=Sun Feb 20 09:11:03 CST 2022, time=2022-02-20, status=1, ipAttribution=)]
    2022-02-20 U波低钾

    学习了

    0

Baidu
map
Baidu
map
Baidu
map